Conclusion and Acknowledgments

A Preparedness Sample Repository to Facilitate Rapid Diagnostic Test Development and Deployment

Key points

  • A preparedness sample repository will help developers get necessary test materials quickly during an outbreak.
  • Receiving these materials quickly improves rapid development, performance characterization, and implementation of emergency use authorization (EUA) tests.

Conclusion

A preparedness repository would facilitate access to specimens and materials that may be difficult to obtain during a response. These specimens and materials would be used to improve rapid development, performance characterization, and implementation of EUA tests during a response. The CDC Biorepository has the expertise, infrastructure, and relationships to support the creation and maintenance of a centralized national preparedness repository.

Authors

Jasmine Chaitram1, Lisa Kalman1, Brad Bowzard1, Carolyn Black2, Dennis Bagarozzi2, Reynolds Salerno1

Centers for Disease Control and Prevention

  • 1Division of Laboratory Systems
  • 2Division of Scientific Resources

Acknowledgments

The Division of Laboratory Systems thanks the following individuals for their contributions to this manuscript:

  • Laura Rose, CDC Office of Laboratory Science and Safety
  • Kim Sapsford, Food and Drug Administration
  • Amy Zale, Centers for Medicare and Medicaid Services
  • Rosemary Humes, Biomedical Advanced Research and Development Authority
  • Marcia Revelez, CDC Division of Laboratory Systems
  • Joanne Andreadis and John Kools, CDC Center for Preparedness and Response
Print
Content Source: